Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 129

1.

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group.

Hassett J, Gjerset GF, Mosley JW, Fletcher MA, Donegan E, Parker JW, Counts RB, Aledort LM, Lee H, Pike MC.

Blood. 1993 Aug 15;82(4):1351-7.

2.

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group.

Fletcher MA, Mosley JW, Hassett J, Gjerset GF, Kaplan J, Parker JW, Donegan E, Lusher JM, Lee H.

Blood. 1992 Aug 1;80(3):831-40.

3.

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group.

Gjerset GF, Pike MC, Mosley JW, Hassett J, Fletcher MA, Donegan E, Parker JW, Counts RB, Zhou Y, Kasper CK, et al.

Blood. 1994 Sep 1;84(5):1666-71.

4.

Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.

Sánchez-Ramón S, Bellón JM, Resino S, Cantó-Nogués C, Gurbindo D, Ramos JT, Muñoz-Fernández MA.

Pediatrics. 2003 Feb;111(2):E168-75.

PMID:
12563091
5.

Effects of human immunodeficiency virus and immune status on magnetic resonance imaging of the brain in hemophilic subjects: results from the hemophilia growth and development study.

Mitchell WG, Nelson MD, Contant CF, Bale JF Jr, Wilson DA, Bohan TP, Fenstermacher MJ.

Pediatrics. 1993 Apr;91(4):742-6.

PMID:
8096634
6.

Serial CD4 and CD8 T-lymphocyte counts and associated mortality in an HIV-2-infected population in Guinea-Bissau.

Lisse IM, Poulsen AG, Aaby P, Knudsen K, Dias F.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 1;13(4):355-62.

PMID:
8948374
7.

[Evolution of CD4 and CD8 lymphocyte subsets in HIV seronegative and seropositive hemophiliacs].

Lorenzo JI, Molina R, Aznar JA.

Sangre (Barc). 1993 Feb;38(1):5-11. Spanish.

PMID:
8470035
8.

[T-lymphocyte immune in HIV-infected people and AIDS patients in China].

Li T, Qiu Z, Wang A, Sheng R.

Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1391-5. Chinese.

PMID:
12509921
9.

Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS).

Nowicki MJ, Karim R, Mack WJ, Minkoff H, Anastos K, Cohen M, Greenblatt RM, Young MA, Gange SJ, Levine AM.

Hum Immunol. 2007 May;68(5):342-9.

PMID:
17462501
11.

T-cell subsets in health, infectious disease, and idiopathic CD4+ T lymphocytopenia.

Laurence J.

Ann Intern Med. 1993 Jul 1;119(1):55-62. Review.

PMID:
8098929
12.

Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth.

Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R.

Pediatrics. 2002 Feb;109(2):E25.

PMID:
11826235
13.

T-lymphocyte subsets in HIV-infected and high-risk HIV-uninfected adolescents: retention of naive T lymphocytes in HIV-infected adolescents. The Adolescent Medicine HIV/AIDS Research Network.

Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson C, Holland C, Crowley-Nowick P, Vermund SH.

Arch Pediatr Adolesc Med. 2000 Apr;154(4):375-80.

PMID:
10768676
15.

HIV-1 and immunological changes during pregnancy: a comparison between HIV-1-seropositive and HIV-1-seronegative women in Nairobi, Kenya.

Temmerman M, Nagelkerke N, Bwayo J, Chomba EN, Ndinya-Achola J, Piot P.

AIDS. 1995 Sep;9(9):1057-60.

PMID:
8527078
16.

Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.

Benito JM, Zabay JM, Gil J, Bermejo M, Escudero A, Sánchez E, Fernández-Cruz E.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):128-35.

PMID:
9052721
17.

Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study.

Moretti S, Alesse E, Di Marzio L, Zazzeroni F, Ruggeri B, Marcellini S, Famularo G, Steinberg SM, Boschini A, Cifone MG, De Simone C.

Blood. 1998 May 15;91(10):3817-24.

18.

[Characteristics of immunophenotypic alterations in 263 HIV/AIDS patients].

Xie J, Qiu ZF, Li TS, Han Y, Zuo LY, Ma XJ, Liu ZY, Wang AX.

Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):965-9. Chinese.

PMID:
16759536
19.

Opportunistic infection and immunologic function in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma treated with chemotherapy.

Sparano JA, Hu X, Wiernik PH, Sarta C, Reddy DM, Hanau L, Henry DH.

J Natl Cancer Inst. 1997 Feb 19;89(4):301-7.

20.

Lymphocyte subsets and viral load in patients with HIV-associated non-Hodgkin's lymphoma treated with anti-CD20 monoclonal antibody and chemotherapy.

De Paoli P, Vaccher E, Tedeschi R, Caffau C, Zanussi S, Bortolin MT, Crepaldi C, Spina M, Tirelli U.

Cancer Immunol Immunother. 2001 May;50(3):157-62.

PMID:
11419183
Items per page

Supplemental Content

Support Center